About Orixha
Orixha’s Mission
Orixha’s mission statement is
« To save the lives of critical care patients through our unique liquid ventilation technology ».
This shared objective was the key impetus behind the creation of Orixha by its seven co-founders: A. Berdeaux MD PharmD, M. Kohlhauer DVM PhD, P. Micheau Eng PhD, M. Nadeau Eng PhD, F. Paublant MBA, R. Tissier DVM PhD, H. Walti, MD PhD,
This commitment was renewed in 2022 when the Orixha’s raison d’être (mission statement) was approved by all the shareholders and included in its corporate charters.
Since its foundation in 2018, several milestones and significant events occurred towards the realization of this shared goal.
The name “Orixha” is a symbol of this fruitful teamwork between Canadian and French researchers as well as their dedication to a faster and more efficient hypothermia solution as it means “cold breath” and is associated with the northern wind for the Huron people.
Management Team
R. Tissier, PhD
Chief Medical Officer
F. Paublant, MBA
Chief Executive Officer
M. Nadeau, Eng. PhD
Chief Technology Officer
S. Perrotto, PhD
Regulatory & Product R&D
M. Libardi, Eng.
Quality & Technology R&D
L. Vauthier
Administrative and Communication
Senior Advisors
P. Micheau, Eng. PhD
IP & Technology
Dr G. Nichol, MD, PhD
US Regulatory and Clinical
M. Kohlhauer, PhD
Preclinical
Scientific Committee
Pr A. Cariou
Dr F. Taccone
Pr JD Ricard
Pr E. Vicaut
Dr L. Lamhaut
Our Industrial Partners
Our Financial Partners
